Status:
RECRUITING
Mobile Instant Messaging-based Lifestyle Intervention for Gestational Diabetes Prevention
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Research Grants Council, Hong Kong
Conditions:
Gestational Diabetes
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The goal of this randomised controlled trial is to test the effectiveness of a mobile instant messaging-based lifestyle intervention in pregnant women at risk of gestational diabetes
Detailed Description
Gestational diabetes mellitus (GDM) is one of the most common medical conditions during pregnancy, affecting about 1 in 7 live births worldwide. There remains a lack of proven preventive strategies fo...
Eligibility Criteria
Inclusion
- Ethnic Chinese singleton pregnant woman in \<14 weeks of gestation
- Aged 18 years or above
- Own a mobile phone with an instant messaging app
- Not participating in similar trials on diabetes or lifestyle modifications
- Have at least one of the following risk factors for GDM:
- Age ≥35 years at the expected date of delivery
- Body mass index (BMI) ≥ 25 kg/m2 pre-pregnancy or in the first trimester
- Family history of diabetes in first-degree relative
- Previous GDM or delivered a baby with birthweight ≥4 kg
Exclusion
- Pre-existing diabetes or other medical conditions that may affect metabolism (e.g., thyroid disorders) or psychiatric disorders
Key Trial Info
Start Date :
January 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2026
Estimated Enrollment :
944 Patients enrolled
Trial Details
Trial ID
NCT06061991
Start Date
January 30 2024
End Date
October 30 2026
Last Update
September 19 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Kwong Wah Hospital
Hong Kong, Hong Kong
2
Princess Margaret Hospital
Hong Kong, Hong Kong
3
Queen Mary Hospital/ Tsan Yuk Hospital
Hong Kong, Hong Kong
4
United Christian Hospital/ Tseung Kwan O Hospital
Hong Kong, Hong Kong